Schedule 13G ownership disclosure

NOVELION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 67001K202

Event date: 2018-11-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
946,842
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-18-004215
Form type
SC 13G
Filer
HIGHBRIDGE CAPITAL MANAGEMENT LLC
CIK
CIK 919185
Filed
Nov 29, 2018
Reporting period
Nov 19, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub